iRadimed Corp (IRMD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Shifts
The current backlog, led by strong pump and monitor sales, offers good visibility into the fourth quarter. The variance between top-line growth and net income was attributed to changes in sales commissions. Future operating expenses are expected to align with current levels.